Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.

Saved in:
Bibliographic Details
Title: Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.
Authors: Miyazawa Y; Department of Urology, Gunma University Graduate School of Medicine & Gunma University Hospital, Maebashi, Japan.
Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 May; Vol. 33 (5), pp. e70488.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1442-2042
DOI:10.1111/iju.70488